Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.

Q4 Medicine

Praxis Pub Date : 2025-05-01 DOI:10.23785/PRAXIS.2025.05.002

Arnoud J Templeton, Vérane Achard, Dilara Akhoundova, Irene A Burger, Daniel Eberli, Daniel Engeler, Andreas Erdmann, Stefanie Fischer, Rainer Grobholz, Anja Lorch, Philip Niederberger, Aurelius Omlin, Alexandros Papachristofilou, Lukas Prause, Katharina Reichel, Cyrill A Rentsch, Mohamed Shelan, Frank Stenner, Petros Tsantoulis, Ursula Vogl, Deborah Zihler, Daniel Zwahlen, Richard Cathomas

{"title":"Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.","authors":"Arnoud J Templeton, Vérane Achard, Dilara Akhoundova, Irene A Burger, Daniel Eberli, Daniel Engeler, Andreas Erdmann, Stefanie Fischer, Rainer Grobholz, Anja Lorch, Philip Niederberger, Aurelius Omlin, Alexandros Papachristofilou, Lukas Prause, Katharina Reichel, Cyrill A Rentsch, Mohamed Shelan, Frank Stenner, Petros Tsantoulis, Ursula Vogl, Deborah Zihler, Daniel Zwahlen, Richard Cathomas","doi":"10.23785/PRAXIS.2025.05.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The landscape of diagnosis and treatment of locally advanced and metastatic prostate cancer has seen an unprecedented evolution in recent years. Incorporation of results from pivotal studies is crucial for state-of-the-art counselling of patients and to inform treatment recommendations. However, in daily practice ambiguous situations may occur or various options may seem adequate. Furthermore, specific national regulations, e.g. availability of diagnostic tools and drug approvals, may influence treatment choices. This paper presents the voting results of a Swiss expert panel that convened in August 2024 and discussed selected questions addressed by an international panel of experts during the Advanced Prostate Cancer Conference held in Lugano in April 2024. The objective is to facilitate national harmonization of diagnosis and treatment of locally advanced and metastatic prostate cancer and thereby providing a basis for discussion with individuals with prostate cancer.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 5","pages":"172-180"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Praxis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23785/PRAXIS.2025.05.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The landscape of diagnosis and treatment of locally advanced and metastatic prostate cancer has seen an unprecedented evolution in recent years. Incorporation of results from pivotal studies is crucial for state-of-the-art counselling of patients and to inform treatment recommendations. However, in daily practice ambiguous situations may occur or various options may seem adequate. Furthermore, specific national regulations, e.g. availability of diagnostic tools and drug approvals, may influence treatment choices. This paper presents the voting results of a Swiss expert panel that convened in August 2024 and discussed selected questions addressed by an international panel of experts during the Advanced Prostate Cancer Conference held in Lugano in April 2024. The objective is to facilitate national harmonization of diagnosis and treatment of locally advanced and metastatic prostate cancer and thereby providing a basis for discussion with individuals with prostate cancer.

查看原文本刊更多论文

晚期前列腺癌管理的跨学科瑞士共识建议。

近年来，局部晚期和转移性前列腺癌的诊断和治疗出现了前所未有的发展。纳入关键研究的结果对于最先进的患者咨询和告知治疗建议至关重要。然而，在日常实践中，可能会出现模棱两可的情况，或者各种选择似乎都是适当的。此外，具体的国家法规，例如诊断工具的可得性和药物批准，可能影响治疗选择。本文介绍了瑞士专家小组于2024年8月召集的投票结果，并讨论了2024年4月在卢加诺举行的晚期前列腺癌会议期间国际专家小组所讨论的选定问题。其目标是促进国家对当地晚期和转移性前列腺癌的诊断和治疗的统一，从而为与前列腺癌患者进行讨论提供基础。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊